Author: Braun, Maya; Sharon, Elad; Unterman, Irene; Miller, Maya; Shtern, Anna Mellul; Benenson, Shmuel; Vainstein, Alexander; Tabach, Yuval
Title: ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic Cord-id: utf2d2kg Document date: 2020_7_18
ID: utf2d2kg
Snippet: Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spillover infection in December 2019 has caused an unprecedented pandemic. SARS-CoV-2, as other coronaviruses, binds its target cells through the angiotensin-converting enzyme 2 (ACE2) receptor. Accordingly, this makes ACE2 research essential for understanding the zoonotic nature of coronaviruses and identifying novel drugs. Here we present a systematic analysis of the ACE2 conservation and co-evolution protein network acro
Document: Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spillover infection in December 2019 has caused an unprecedented pandemic. SARS-CoV-2, as other coronaviruses, binds its target cells through the angiotensin-converting enzyme 2 (ACE2) receptor. Accordingly, this makes ACE2 research essential for understanding the zoonotic nature of coronaviruses and identifying novel drugs. Here we present a systematic analysis of the ACE2 conservation and co-evolution protein network across 1671 eukaryotes, revealing an unexpected conservation pattern in specific metazoans, plants, fungi, and protists. We identified the co-evolved protein network and pinpointed a list of drugs that target this network by using data integration from different sources. Our computational analysis found widely used drugs such as nonsteroidal anti-inflammatory drugs and vasodilators. These drugs are expected to perturbate the ACE2 network affecting infectivity as well as the pathophysiology of the disease.
Search related documents:
Co phrase search for related documents- absence presence and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- absence presence and additional source: 1, 2
- absence presence and long protein: 1, 2, 3, 4
- absence presence and low conservation: 1
- action mechanism and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- action mechanism and long protein: 1, 2
- action mechanism understanding and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
- acute sars cov respiratory syndrome coronavirus and additional class: 1, 2
- acute sars cov respiratory syndrome coronavirus and additional source: 1, 2
- acute sars cov respiratory syndrome coronavirus and long protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute sars cov respiratory syndrome coronavirus and low conservation: 1, 2
Co phrase search for related documents, hyperlinks ordered by date